1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,016 | 0,039 | 09:49 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | LIFE: Lifecare ASA Q2 2026 results | 2 | Oslo Børs | ||
| 12.08. | Lifecare ASA (LIFE): Invitation to presentation of Q2 2026 results 19 August at 08.45 CEST | 1 | Oslo Børs | ||
| 02.07. | Lifecare ASA: LIFE: Update on production transfer and longevity programme | 2 | Oslo Børs | ||
| 26.06. | Lifecare ASA: LIFE: Operational update regarding Lifecare Germany GmbH (i.L) | 4 | Oslo Børs | ||
| 22.06. | Lifecare ASA: Share capital increase registered | 5 | Oslo Børs | ||
| 22.06. | Lifecare ASA: LIFE: Independent tissue analysis confirms no adverse tissue response after six months of implantation | 3 | Oslo Børs | ||
| 12.06. | Lifecare ASA: Final results following expiry of exercise period for Warrants Series 2 issued in connection with Rights Issue | 6 | Oslo Børs | ||
| 12.06. | Lifecare ASA: Last day of the Exercise Period for Warrants Series 2 issued in connection with the Rights Issue | 1 | Oslo Børs | ||
| LIFECARE ASA Aktie jetzt für 0€ handeln | |||||
| 10.06. | Lifecare ASA: Mandatory notification of trade | 2 | Oslo Børs | ||
| 10.06. | Lifecare ASA: Lifecare completes first six-month implant evaluation with continued functionality and no adverse biological response | 1 | Oslo Børs | ||
| 05.06. | Lifecare ASA: Last day of trading in Warrants Series 2 issued in connection with the Rights Issue | 2 | Oslo Børs | ||
| 03.06. | Lifecare ASA: Mandatory notification of trade | 1 | Oslo Børs | ||
| 01.06. | Lifecare ASA: Commencement of the Exercise Period for Warrants Series 2 issued in connection with the Rights Issue | 2 | Oslo Børs | ||
| 29.05. | Lifecare ASA: Exercise price for Warrants Series 2 issued in connection with the Rights Issue | - | Oslo Børs | ||
| 15.05. | LIFE: Lifecare ASA Q1 2026 results | 3 | Oslo Børs | ||
| 07.05. | Lifecare ASA: Financial calendar | 1 | Oslo Børs | ||
| 07.05. | Lifecare ASA (LIFE): Invitation to Q1 2026 results presentation | 3 | Oslo Børs | ||
| 23.04. | Lifecare ASA: Minutes from Annual General meeting 2026 | 17 | Oslo Børs | ||
| 01.04. | Lifecare ASA: Disclosure of shareholding | 13 | Oslo Børs | ||
| 27.03. | Lifecare ASA: Shareholding disclosure - Nordnet AB 2 | 11 | Oslo Børs |
1 2 3 Weiter >>
42 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,069 | +1,46 % | Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Receives FDA Orphan Drug Designation for Autologous Islet Transplantation for Prevention of Diabetes Due to Total Pancreatectomy | TORONTO and BOSTON, June 17, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. ("Sernova" or the "Company") (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO), a leading regenerative medicine company focused... ► Artikel lesen | |
| BOSTON SCIENTIFIC | 43,295 | +0,35 % | dailyAktien: Boston Scientific - Langfristiges Stärkesignal | ||
| PAUL HARTMANN | 201,00 | -0,50 % | Januar bis Juni 2026: PAUL HARTMANN steigert erneut Umsatz und Ergebnis | Heidenheim (ots) - - Erfolgreiches 1. Halbjahr: Umsatzerlöse steigen auf 1.252,0 Mio. EUR, organisches Umsatzwachstum von 3,3 %; bereinigtes EBITDA liegt mit 151,7 Mio. EUR um 25,9 Mio. EUR über Vorjahreswert-... ► Artikel lesen | |
| SYSMEX | 10,535 | +2,53 % | Sysmex Corporation Announces Increase In Q1 Profit | TOKYO (dpa-AFX) - Sysmex Corporation (SSMXY.PK) revealed a profit for its first quarter that Increased, from the same period last yearThe company's bottom line totaled JPY8.691 billion, or JPY14.17... ► Artikel lesen | |
| EMBECTA | 4,640 | +3,50 % | Embecta Corp.: embecta appoints Nimish Muzumdar as SVP and President, North America | PARSIPPANY, N.J., June 16, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical... ► Artikel lesen | |
| ADDLIFE | 14,410 | +0,21 % | AddLife AB: Interim Report January 1 - June 30, 2026 | Positive development across AddLife's companies"AddLife's companies are performing well across the board, with stronger margins, good growth and increased cash flow. Ourimprovement efforts are yielding... ► Artikel lesen | |
| ENOVIS | 23,000 | +2,68 % | Enovis Corporation: Enovis Announces Second Quarter 2026 Results | Second-quarter sales growth of 3% on a reported basis, 5% organicSecond-quarter Reconstructive sales grew 8% on a reported basis, 6% organicReaffirmed full-year 2026 guidance for revenue, adjusted... ► Artikel lesen | |
| SI-BONE | 16,900 | -1,17 % | SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance | Delivered ~15% WW revenue growth and ~178% increase in adjusted EBITDA ~19% increase in U.S. physician base Second Quarter 2026 Financial Highlights (all comparisons are to the prior year period)... ► Artikel lesen | |
| PULMONX | 1,960 | -0,51 % | Pulmonx Corporation: Pulmonx Reports Second Quarter 2026 Financial Results | REDWOOD CITY, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) ("Pulmonx" or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported... ► Artikel lesen | |
| KOOTH | 1,700 | 0,00 % | Edison Group: Edison Issues Report on Kooth (KOO) | London, United Kingdom--(Newsfile Corp. - July 31, 2026) - Edison issues report on Kooth (AIM: KOO)Kooth provides clinically accredited digital mental health support, focused on children and young... ► Artikel lesen | |
| PEIJIA MEDICAL | 0,510 | -1,92 % | PEIJIA-B (09996): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2026 | ||
| BACTIGUARD | 1,205 | -1,63 % | Bactiguard Holding AB: Bactiguard Holding AB's interim report second quarter 2026 | Solid performance driven by revenue growth
Second quarter 2026 (April - June)Total revenue amounted to SEK 57.1 (52.1) million, an increase of SEK 4.9 million corresponding to 9%.Net sales amounted... ► Artikel lesen | |
| SCIBASE | 1,885 | -6,68 % | SciBase: Interim report | STOCKHOLM, Aug. 19, 2026 /PRNewswire/ --
January 1 - June 30, 2026The second quarter in figures Net sales were TSEK 15,308 (8,791), +74%, cleared for currency effects +84%. ... ► Artikel lesen | |
| PHC HOLDINGS | 7,800 | 0,00 % | PHC Holdings Corporation: Leeds NHS Innovation to Accelerate Global Adoption of AI-enabled Pathology for Cancer Diagnostics Through Epredia Partnership | A pioneering pathology technology developed by Leeds Teaching Hospitals NHS Trust is set for international deployment after securing a commercial agreement with Epredia, a global leader in precision... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,140 | -1,83 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen |
LIFECARE ASA gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -15,54 % bei einem Aktienkurs von 0,021 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu LIFECARE ASA finden Sie auf Wallstreet Online.